SCN9A and peripheral neuropathy: In humans, loss-of-function mutations in SCN9A, the gene encoding NaV1.7, leads to congenital insensitivity to pain, while several gain-of-function mutations in SCN9A and SCN10A (the gene encoding NaV1.8) are associated with painful peripheral neuropathies [5,6,7].